The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer

European Journal of Internal Medicine

Volumn 22, Issue 5, 2011, Pages

  Liu, Liang Ming ^a   Yan, Ming Guo ^b   Yang, Dao Hua ^a   Sun, Wei Wei ^a   Zhang, Ji Xiang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Gastric cancer; Gastric precancerous lesions; Intestinal metaplasia; PIAS3

Indexed keywords

FLUORESCENT DYE; MESSENGER RNA; PROTEIN; PROTEIN INHIBITOR OF ACTIVATED SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; PROTEIN INHIBITOR OF ACTIVATED STAT; UNCLASSIFIED DRUG;

ARTICLE; ATROPHIC GASTRITIS; CANCER STAGING; CHRONIC ATROPHIC GASTRITIS; CHRONIC SUPERFICIAL GASTRITIS; COLON METAPLASIA; ENDOSCOPIC BIOPSY; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MICROSCOPY; OPTICAL DENSITY; PERIODIC ACID SCHIFF STAIN; PRECANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINDLE CELL; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STOMACH MUCOSA LESION;

ADULT; AGED; BIOPSY; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTEIN INHIBITORS OF ACTIVATED STAT; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 80955179046     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.04.002     Document Type: Article

References (31)

1. R.J. Cahill, C. Kilgallen, and S. Beattie Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma Gut 38 1996 177 181 (Pubitemid 26046812)
2. M.I. Filipe, N. Munoz, and I. Matko Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia Int J Cancer 57 1994 324 329 (Pubitemid 24168604)
3. N. Uemura, S. Okamoto, and S. Yamamoto Helicobacter pylori infection and development of gastric cancer N Engl J Med 345 2001 784 789
4. J. Guarner, R. Herrera-Goepfert, and A. Mohar Gastric atrophy and extent of intestinal metaplasia in cohort of Helicobacter pylori-infected patients Hum Pathol 32 1 2001 31 35 (Pubitemid 32150625)
5. P. Correa, M.B. Piazuelo, and K.T. Wilson Pathology of gastric intestinal metaplasia: clinical implications Am J Gastroenterol 105 3 2010 493 498
6. P. Baracchini, E. Fulcheri, and G. Lapertosa Patterns of intestinal metaplasia in gastric biopsies. A comparison of different histochemical classifications Histochem J 23 1991 1 9
7. S.G. Gao, L.D. Wang, and Z.M. Fan Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China World J Gastroenterol 11 30 2005 4634 4637
8. M. Dinis-Ribeiro, C. Lopes, and A. da Costa-Pereira A follow-up model for patients with atrophic chronic gastritis and intestinal metaplasia J Clin Pathol 57 2 2004 177 182 (Pubitemid 38177758)
9. H. Tanaka, T. Tsukamoto, and T. Mizoshita Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach Virchows Arch 447 5 2005 806 815 (Pubitemid 41728868)
10. T. Evrensel, O. Manavoglu, and C. Ozyardimci Subtypes of intestinal metaplasia and their relationship to Helicobacter pylori J Environ Pathol Toxicol Oncol 15 2-4 1996 221 224 (Pubitemid 27280411)
11. M. Rugge, F. Farinati, and R. Baffa Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up. Interdisciplinary Group on Gastric Epithelial Dysplasia Gastroenterology 107 1994 1288 1296 (Pubitemid 24328264)
12. C. Borghouts, H. Tittmann, and N. Delis The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death Mol Cancer Res 8 4 2010 539 553
13. Z. Yagil, G. Kay, and H. Nechushtan A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells J Immunol 182 4 2009 2168 2175
14. C.D. Chung, J. Liao, and B. Liu Specific inhibition of Stat3 signal transduction by PIAS3 Science 278 5344 1997 1803 1805 (Pubitemid 27527648)
15. J.E. Darnell, I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcription activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421 (Pubitemid 24217131)
16. Y. Ogata, T. Osaki, and T. Naka Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3K/Akt inactivation Neoplasia 8 10 2006 817 825 (Pubitemid 44564837)
17. E.C. Brantley, L.B. Nabors, and G.Y. Gillespie Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression Clin Cancer Res 14 15 2008 4694 4704
18. L.M. Wang, and S. Banerjee Differential PIAS3 expression in human malignancy Oncol Rep 11 6 2004 1319 1324
19. C.B. Jackson, and A.S. Giraud STAT3 as a prognostic marker in human gastric cancer J Gastroenterol Hepatol 24 2009 646 651
20. D.Y. Kim, S.T. Cha, and D.H. Ahn STAT3 expression in gastric cancer indicates a poor prognosis J Gastroenterol Hepatol 24 4 2009 646 651
21. L.M. Liu, M.G. Yan, and D.H. Yang PIAS3 expression in human gastric carcinoma and its adjacent non-tumor tissues Clin Res Hapatol Gastroenterol 2011 Feb 18; [Epub ahead of print]
22. Y. Sasano, J.X. Zhu, and M. Tsubota Gene expression of MMP8 and MMP13 during embryonic development of bone and cartilage in the rat mandible and hind limb J Histochem Cytochem 50 2002 325 332 (Pubitemid 34171057)
23. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Liver Flukes and Helicobacter pylori International Agency for Research on Cancer Schistosomes Volume 61 1994 World Health Organization Lyon, France
24. N. Nakajima, Y. Ito, and K. Yokoyama The expression of murine double minute 2 (MDM2) on Helicobacter pylori- induced intestinal metaplasia and gastric cancer J Clin Biochem Nutr 44 2009 196 202
25. G. Niu, K.L. Wright, and M. Huang Constitutive STAT3 activity upregulates VEFG expression and tumor angiogenesis Oncogene 21 13 2002 2000 2008 (Pubitemid 34270888)
26. C. Levy, A. Sonnenblick, and E. Razin Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3 Mol Cell Biol 23 24 2003 9073 9080 (Pubitemid 37499797)
27. C. Levy, H. Nechushtan, and E. Razin A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor J Biol Chem 277 3 2002 1962 1966 (Pubitemid 34968775)
28. J.H. Man, H.Y. Li, and P.J. Zhang PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Nucleic Acids Res 34 19 2006 5552 5566
29. A.M. Jiménez-Lara, M.J. Heine, and H. Gronemeyer PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2 FEBS Lett 526 1-3 2002 142 146 (Pubitemid 35245709)
30. E. Tolkunova, A. Malashicheva, and V.N. Parfenov PIAS proteins as repressors of Oct4 function J Mol Biol 374 5 2007 1200 1212 (Pubitemid 350122540)
31. H.D. Jang, K. Yoon, and Y.J. Shin PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit J Biol Chem 279 23 2004 24873 24880 (Pubitemid 38725356)